Back to UBS Group AG UBS Group AG

CRDLCRDL
Showing 8 of 19 quarters

Position history for UBS Group AGUBS Group AG's holdings in CARDIOL THERAPEUTICS INC

UBS Group AG holds 8,471 shares of CRDL (CARDIOL THERAPEUTICS INC), worth $8,979 as of 2026-Q2. The position was decreased (-1.6% shares).

Current Value

$8,979

Current Shares

8,471

Total Value Change

+$3,732

Total Shares Change

+5,821

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
8,471
-1.6%
$8,9790.0%$1.06
0
2026-Q1
Decreased
8,609
-48.0%
$11,6220.0%$1.01
0
2025-Q4
Decreased
16,549
-69.1%
$15,7880.0%$0.97
0
2025-Q3
Decreased
53,490
-61.6%
$57,2340.0%$1.14
0
2025-Q2
Decreased
139,244
-72.0%
$189,3720.0%$1.41
0
2025-Q1
Increased
497,857
+112.0%
$482,9220.0%$0.96
39
2024-Q4
Increased
234,818
+8761.1%
$300,5680.0%$1.28
38
2024-Q3
Increased
2,650
+6.0%
$5,2470.0%$2.07
11

Other major holders of CRDL: Mirae Asset Global Investments Co., Ltd., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used